Celsion CEO Interviewed by The Wall Street Reporter.Business/Technology Editors COLUMBIA, Md.--(BUSINESS WIRE)--Feb. 10, 2000 Celsion Corporation (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:CELN) announced today that company president and Chief Executive Officer, Spencer J. Volk, was interviewed this week by The Wall Street Reporter, a real audio, online interview forum. The interview, in which Volk discusses the status of Celsion's various clinical studies, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. applications, and on-going commercialization phase, is available at the Wall Street Reporter's Web site, located at www.wallstreetreporter.com. In the interview, Volk explains the significance of Celsion's breast cancer and benign prostatic hyperplasia benign prostatic hyperplasia n. Abbr. BPH A nonmalignant enlargement of the prostate gland commonly occurring in men after the age of 50, and sometimes leading to compression of the urethra and obstruction of the flow of urine. (BPH) systems, which are undergoing the clinical trials required for FDA approval. He describes the Company's strategic partnerships with leading universities and medical centers in the United States. Discussions featured on The Wall Street Reporter are designed to furnish investors with information about viable companies across the marketplace. Statements should not be construed as investment recommendations, or buy/sell advice. These interviews do not constitute paid reports, but rather are an integral part of the Reporter's customer services. About Celsion Corporation Celsion Corporation is a research and development company dedicated to commercializing medical treatment systems for cancer and other diseases using focused heat delivered by patented microwave technology. Clinicals and further development of the Company's treatment systems are being conducted by leading institutions such as Duke University Medical Center, Harbor UCLA Medical Center UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles in Los Angeles, California. It is rated as one of the top three hospitals in the United States and is the top hospital on the West Coast according to US News & World Report. , Columbia Hospital (a Columbia/HCA Healthcare member), Montefiore Medical Center Montefiore Medical Center, in the Bronx, New York, is the university hospital of the Albert Einstein College of Medicine. The hospital, named after Moses Montefiore, is one of the 50 largest employers in New York State [1]. , Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, , the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). at San Francisco, and Duke University. For more information about Celsion Corporation, visit www.celsion.com. Forward-looking statements in this release are made pursuant to the &uot;safe harbor&uot; provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, possible changes in cost of materials, expense items, capital expenditures, capital structure, and other financial items; introduction of new products and possible acquisitions of assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion